BRIEF-Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program
ReutersJan 10, 2025 11:17 PM
Jan 10 (Reuters) - Traws Pharma Inc TRAW.O:
EXPERT SYSTEMS: ANNOUNCED A SIGNIFICANT MILESTONE IN A DEVELOPMENT OF TRAWS PHARMA'S H5N1 ANTIVIRAL PROGRAM
EXPERT SYSTEMS: WITH COMPLETION OF PHASE 1 TRIALS, PLANS ARE UNDERWAY TO INITIATE PHASE 2 EFFICACY STUDIES IN FIRST HALF OF 2025
Source text: ID:nPn6sWG9ma
Further company coverage: TRAW.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: For information purposes only. Past performance is not indicative of future results.
Related Articles
Is Intel Ready for a Comeback?
While the stock may appear attractive due to its low valuation, Intel’s ability to execute its strategies effectively remains uncertain. The company’s heavy reliance on the success of its Foundry business and its ability to compete with industry leaders like TSMC and Samsung add layers of complexityTradingKey
6 hours ago
AI Stocks Climb Amid Stargate Buzz: Who’s the Next Nvidia?
TradingKey - On Wednesday, President Donald Trump’s new AI initiative sent Oracle shares soaring, closing up 7%, while Arm Holdings gained 16%. The bullish momentum extended to other AI-related stocks, with Nvidia rising 4%.TradingKey
8 hours ago
Japan: Believe in Long-Term Recovery. Buy!
Under the long-term influence of the three arrows of Abenomics and the diminishing impact of the pandemic, Japan's economy has entered a recovery phase (excluding 2024). The emergence of inflation and a significant rise in wages, driven by the 2024 Shuntō wage negotiations, prompted the BOJ...TradingKey
Tue, Jan 21
US Stock Market’s 2025 Outlook: Navigating the Shifting Landscape
TradingKey - Anyone who has invested in US stocks in 2024 will be happy. The US stock market has delivered an absolutely blockbuster performance so far this year, with the S&P 500 Index soaring 26.9% year-to-date (as of December 16), reaching record highs.TradingKey
Mon, Dec 30
